Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Colorectal Neoplasms

  Free Subscription


17.10.2022

1 Am J Epidemiol
4 Ann Surg
16 Ann Surg Oncol
4 BMC Cancer
2 BMC Gastroenterol
2 Br J Cancer
1 Cancer Res
1 Clin Cancer Res
1 Eur J Surg Oncol
1 Gut
1 J Natl Cancer Inst
1 N Engl J Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Epidemiol

  1. DEYOREO M, Rutter CM, Lee SD
    Two-Stage Modeling to Identify How Colorectal Cancer Risk Changes With Period and Cohort.
    Am J Epidemiol. 2022 Oct 12. pii: 6759399. doi: 10.1093.
    PubMed         Abstract available


    Ann Surg

  2. ARRON MNN, Greijdanus NG, Bastiaans S, Vissers PAJ, et al
    Long-Term Oncological Outcomes After Colorectal Anastomotic Leakage: A Retrospective Dutch Population-based Study.
    Ann Surg. 2022;276:882-889.
    PubMed         Abstract available

  3. ASNONG A, D'Hoore A, Van Kampen M, Wolthuis A, et al
    The Role of Pelvic Floor Muscle Training on Low Anterior Resection Syndrome: A Multicenter Randomized Controlled Trial.
    Ann Surg. 2022;276:761-768.
    PubMed         Abstract available

  4. DOHRN N, Yikilmaz H, Laursen M, Khesrawi F, et al
    Intracorporeal Versus Extracorporeal Anastomosis in Robotic Right Colectomy: A Multicenter, Triple-blind, Randomized Clinical Trial.
    Ann Surg. 2022;276:e294-e301.
    PubMed         Abstract available

  5. DATTA J, Narayan RR, Goldman DA, Chatila WK, et al
    Distinct Genomic Profiles are Associated With Conversion to Resection and Survival in Patients With Initially Unresectable Colorectal Liver Metastases Treated With Systemic and Hepatic Artery Chemotherapy.
    Ann Surg. 2022;276:e474-e482.
    PubMed         Abstract available


    Ann Surg Oncol

  6. NARAYAN RR, Datta J, D'Angelica MI
    ASO Author Reflections: Ras-p53 Cooperativity Predicts Recurrence Patterns After Resection of Colorectal Liver Metastases with Adjuvant Local and Systemic Chemotherapy.
    Ann Surg Oncol. 2022;29:7589-7590.
    PubMed        

  7. LUO W, Lu T, Xiao Y
    Response to Letter to the Editor: "Comments to Superior Mesenteric Artery First Approach for Right Colectomy" by Jens Marius Nesgaard et al.
    Ann Surg Oncol. 2022;29:7925-7926.
    PubMed        

  8. JUDGE SJ, Cho M, Gholami S
    Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy by Narayan et al.
    Ann Surg Oncol. 2022;29:7246-7247.
    PubMed        

  9. NESGAARD JM, Stimec BV, Ignjatovic D
    Comments on Superior Mesenteric Artery First Approach for Right Colectomy.
    Ann Surg Oncol. 2022;29:7923-7924.
    PubMed        

  10. DELHORME JB, Sauvinet G, Severac F, Diab S, et al
    ASO Visual Abstract: Peritoneal Metastases of Colorectal Origin Treated with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy-The Efficiency of Mitomycin C.
    Ann Surg Oncol. 2022;29:7577-7578.
    PubMed        

  11. DELHORME JB, Sauvinet G, Severac F, Diab S, et al
    Peritoneal Metastases of Colorectal Origin Treated with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: The Efficiency of Mitomycin C.
    Ann Surg Oncol. 2022;29:7568-7576.
    PubMed         Abstract available

  12. NARAYAN RR, Datta J, Goldman DA, Aveson VG, et al
    Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy.
    Ann Surg Oncol. 2022;29:7579-7588.
    PubMed         Abstract available

  13. SONAL S, Deshpande V, Ting DT, Cusack JC, et al
    Molecular Basis of Extramural Vascular Invasion (EMVI) in Colorectal Carcinoma.
    Ann Surg Oncol. 2022;29:7372-7382.
    PubMed         Abstract available

  14. SONAL S, Berger DL
    ASO Author Reflections: Colorectal Cancers with Extramural Vascular Invasion Are Associated with a Low Immune Microenvironment.
    Ann Surg Oncol. 2022;29:7383.
    PubMed        

  15. SONAL S, Deshpande V, Ting DT, Cusack JC, et al
    ASO Visual Abstract: Molecular Basis of Extramural Vascular Invasion (EMVI) in Colorectal Carcinoma : Tumor Microenvironment in EMVI-Positive Colorectal Carcinoma.
    Ann Surg Oncol. 2022;29:7384-7385.
    PubMed        

  16. NARAYAN RR, Datta J, D'Angelica MI
    ASO Visual Abstract: Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy.
    Ann Surg Oncol. 2022;29:7591.
    PubMed        

  17. LIBERALE G, Moreau M, Repullo D
    Comments on "The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-analysis".
    Ann Surg Oncol. 2022;29:7933-7934.
    PubMed        

  18. FLOOD MP, Kong JCH, Heriot AG
    Reply to Comments on "The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-analysis".
    Ann Surg Oncol. 2022;29:7935-7936.
    PubMed        

  19. DAWOOD ZS, Alaimo L, Lima HA, Moazzam Z, et al
    Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies Among Patients Who Underwent Resection of Colorectal Cancer-A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2022 Oct 11. pii: 10.1245/s10434-022-12641.
    PubMed         Abstract available

  20. AQUINA CT, Brown ZJ, Beane JD, Ejaz A, et al
    ASO Visual Abstract: Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis.
    Ann Surg Oncol. 2022 Oct 11. pii: 10.1245/s10434-022-12652.
    PubMed        

  21. ITO K, Osakabe M, Sugimoto R, Yamada S, et al
    Differential Expression in the Tumor Microenvironment of mRNAs Closely Associated with Colorectal Cancer Metastasis.
    Ann Surg Oncol. 2022 Oct 12. pii: 10.1245/s10434-022-12574.
    PubMed         Abstract available


    BMC Cancer

  22. YAN X, Hong B, Feng J, Jin Y, et al
    B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition.
    BMC Cancer. 2022;22:1053.
    PubMed         Abstract available

  23. VEENSTRA CM, Ellis KR, Abrahamse P, Ward KC, et al
    A dyadic survey study of partner engagement in and patient receipt of guideline-recommended colorectal cancer surveillance.
    BMC Cancer. 2022;22:1060.
    PubMed         Abstract available

  24. WANG S, Yuan Z, Wang Y, Zhao X, et al
    Modifiable lifestyle factors have a larger contribution to colorectal neoplasms than family history.
    BMC Cancer. 2022;22:1051.
    PubMed         Abstract available

  25. ZHANG S, Pan G, Liu Z, Kong Y, et al
    Association of levels of metabolites with the safe margin of rectal cancer surgery: a metabolomics study.
    BMC Cancer. 2022;22:1043.
    PubMed         Abstract available


    BMC Gastroenterol

  26. LI Y, Du Y, Xue C, Wu P, et al
    Efficacy and safety of anti-PD-1/PD-L1 therapy in the treatment of advanced colorectal cancer: a meta-analysis.
    BMC Gastroenterol. 2022;22:431.
    PubMed         Abstract available

  27. ALYABSI MS, Alqarni AH, Almutairi LM, Algarni MA, et al
    The 30-day hospital readmission and mortality after surgery in colorectal cancer patients.
    BMC Gastroenterol. 2022;22:434.
    PubMed         Abstract available


    Br J Cancer

  28. LI SJ, Seedher T, Sharples LD, Benton SC, et al
    Impact of changes to the interscreening interval and faecal immunochemical test threshold in the national bowel cancer screening programme in England: results from the FIT pilot study.
    Br J Cancer. 2022;127:1525-1533.
    PubMed         Abstract available

  29. MELTZER S, Negard A, Bakke KM, Hamre HM, et al
    Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancer.
    Br J Cancer. 2022 Oct 13. pii: 10.1038/s41416-022-02004.
    PubMed         Abstract available


    Cancer Res

  30. LOEVENICH LP, Tschurtschenthaler M, Rokavec M, Silva MG, et al
    SMAD4 loss induces c-MYC-mediated NLE1 upregulation to support protein biosynthesis, colorectal cancer growth and metastasis.
    Cancer Res. 2022 Oct 11. pii: 709708. doi: 10.1158/0008-5472.CAN-22-1247.
    PubMed         Abstract available


    Clin Cancer Res

  31. SATHE A, Mason K, Grimes SM, Zhou Z, et al
    Colorectal cancer metastases in the liver establish immunosuppressive spatial networking between tumor associated SPP1+ macrophages and fibroblasts.
    Clin Cancer Res. 2022 Oct 14. pii: 709778. doi: 10.1158/1078-0432.CCR-22-2041.
    PubMed         Abstract available


    Eur J Surg Oncol

  32. CHEN YH, Su YC, Hsu CW, Hsieh MC, et al
    Mortality of patients with metastatic colorectal cancer who received elective or emergent operation after exposure to bevacizumab: A nationwide database study.
    Eur J Surg Oncol. 2022 Oct 1. pii: S0748-7983(22)00688.
    PubMed         Abstract available


    Gut

  33. LI C, Wang Y, Liu D, Wong CC, et al
    Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis.
    Gut. 2022;71:2253-2265.
    PubMed         Abstract available


    J Natl Cancer Inst

  34. SHIH YT, Xu Y, Bradley C, Giordano SH, et al
    Costs Around the First Year of Diagnosis for 4 Common Cancers Among the Privately Insured.
    J Natl Cancer Inst. 2022;114:1392-1399.
    PubMed         Abstract available


    N Engl J Med

  35. BRETTHAUER M, Loberg M, Wieszczy P, Kalager M, et al
    Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.
    N Engl J Med. 2022 Oct 9. doi: 10.1056/NEJMoa2208375.
    PubMed         Abstract available


    PLoS One

  36. KO CY, Yao CC, Li YC, Lu LS, et al
    Clinical outcomes of endoscopic submucosal dissection for colorectal neoplasms: A single-center experience in Southern Taiwan.
    PLoS One. 2022;17:e0275723.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: